These pathways suggest a hyper-activated status in NOD2hi patients, in line with the higher activation and immune response found in Crohn’s disease patients without NOD2 mutations, exhibiting increased cytokine receptors and decreased microRNA expression (32). The gene discussed is NOD2; the disease is Crohn disease.